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ABSTRACT 
Polycystic Ovarian Syndrome is the most common disease in the female population among 
adolescence and reproductive age group mainly due to the adoption of westernized culture. 
Polycystic Ovarian Syndrome (PCOS) is a physiological disorder that causes many negative effects 
involving a variety of systems in the body, such as the endocrine, metabolic, psychological, and 
reproductive systems. The complex symptomatology of PCOS makes very difficult to treat as a 
whole. In Ayurveda also no disease can be compared directly with PCOS. Some of clinical 
symptoms of PCOS may simulate Granthibhoota Artava dushti and if not treated early lead to the 
full manifestations and complications of PCOS. A 26 year old female came to OPD of Streeroga of 
IPGT & RA, having the complaints of irregular cycle, weight gain and failure to conceive since 2 
years of active married life with a previous history of abortion. Sonography revealed bulky ovaries 
with multiple small follicles. Based on clinical findings along with sonological evidences Polycystic 
Ovarian Syndrome was diagnosed and a treatment protocol was selected for managing the PCOS 
and finally to achieve conception. Palasadi basti was selected followed by Pathadi choorna orally 
with warm water as internal medicine. The treatment was done for 3 months and during follow up 
the cycles became regular and finally the patient got conceived within 2 months. 
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INTRODUCTION 
Polycystic ovarian syndrome and Obesity are 
the most common metabolic disorders that are 
associated with sub-fertility. PCOS patients are 
presented with a variety of symptoms like menstrual 
abnormalities, increasing obesity, infertility, acne, 
acanthosis nigricans and hirsutism. Women with 
PCOS patients are sub fertile, and this may be 
exaggerated by obesity, metabolic, inflammatory and 
endocrine abnormalities on ovulatory function, 
oocyte quality, and endometrial receptivity1. Women 
with PCOS have a 30-50% of risk of miscarriage, 
which is 3 times higher than normal women.[2] Even 
though Ovulation can be restored by medication, 
anovulatory patients have decreased cumulative 
pregnancy rates when compared with other sub 
fertile patients[3] and exhibit a higher rate of 
implantation failure and spontaneous miscarriage.[4] 
The long term complications of PCOS include 
diabetes, hypertension, abdominal obesity, risk of 
cardiovascular diseases, endometrial hyperplasia and 
carcinoma. In this modernized world the prevalence 
of PCOS is increasing due to faulty dietary habits and 
lifestyle. Moreover a stressful life of partners in 
today’s era increases the infertility rate among 
couples. As it is a multifactorial disease with complex 
involvement of more than two systems in the body, 
early diagnosis and management of PCOS is a 
necessity to prevent further complications. 
PCOS cannot be directly correlated with any 
gynaecological disorders mentioned in Ayurveda. The 
Artava term is also used to represent ovum and 
hence among the 8 Artavadushtis which leads to 
Abeejata (anovulation), Granthibhoota Artavadushti[5] 
have the features like Granthila artava can be 
correlated with the termination of follicle maturation 
and became cystic in nature. This prevents proper 
growth of follicle to release a mature ovum as in 
polycystic ovary. On comparing the Artava as raja i.e., 
menstruation, clinical features of both Vata and 
kaphadushta Artava can be seen in Granthibhoota 
Artava like Oligomenorrhoea (chirat nishichyate) if 
vata predominance is there and kapha predominance 
seen as amenorrhoea followed by heavy bleeding 
with endometrial hyperplasia (Majjosamsrushtam, 
Prabhootam Vibandham) along with Abeejata[6] 
(Anovulation). Ayurveda explained mainly four 
etiological factors like unhealthy lifestyle 
(Mithyachara), menstrual disorders/ovarian factors 
(Artava dushti), genetic defects (Beeja dosha) and 
certain unknown factors (Daivata) are responsible 
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for the development of female genital disorders 
(Yonirogas)[7] and it is seems that all these etiologies 
contribute to the development of PCOS as a whole. 
Mithyachara along with existing Artavadushti, plays 
an important role in the pathogenesis of PCOS which 
further leads to the various Yonivyapads like 
Jataghni(recurrent abortion)8, Vamini (luteal phase 
defect)[9], Na garbham gruhnati (infertility).[10] As the 
ultimate effect of Artava dushti being Abeejatva 
(anovulation) and various Yonirogas, diagnosis and 
treatment of Artava dushti is of most important as it 
hinders the main function of female genital tract 
along with further complications like Asrigdara, Arsa, 
Gulma and Vatapradhana daruna disorders.[11] As per 
Susruta, Vyana and Apana prokopa is seen in 
Artavadosha “sukradoshapramehastu vyanapana 
prakopaja.[12] Vata also plays an important role in the 
regulation of HPO axis. Ayurvedic management of 
PCOS helps to regularise the cycle, promotes 
ovulation, improves oocyte quality and endometrial 
receptivity and helps to achieve pregnancy with low 
risk of miscarriage. 
Case report 
Patient history with presenting complaints: A 
26 year old female came to OPD of Prasuti-Streeroga 
of IPGT & RA, on 21/4/17 having the complaints of 
irregular cycle, sudden increase in weight and 
infertility since 2 years of active married life with a 
previous history of one abortion. 
History of presenting complaints: The 
complaints started 2 years back as irregular and 
delayed menses with a previous history of regular 
cycle after the menarche at 13 years of age. Her 
marriage was at the age of 24 years with a 
nonconsanginous man of age 30 years. The menstrual 
disturbances started just before marriage and during 
the first 3 months of marriage life she got conceived. 
But at 2nd month of pregnancy, spontaneous bleeding 
occurred unexpectedly and complete abortion 
occurred. The patient was advised not to conceive for 
next 3 months by gynaecologist. After the abortion 
the complaints got worsened with irregular cycles, 
excessive weight gain (approximately around 6-8 kg 
in 2 months), increase in acne, heaviness of body etc. 
Then they tried for a child, but even after 1 year of 
unprotected intercourse she failed to conceive. So the 
couple decided to take Ayurvedic treatment for the 
same and came to our hospital. 
Personal History: She had a habit of taking 
excessive sweet and salty substances, junk foods, fast 
food, cool drinks etc., with sedentary lifestyle and had 
a bad habit of chewing pan masala since 2-3 years. 
She was very anxious and irritable in nature. She had 
a normal appetite with regular bowel habits and 
increased sleep hours with day sleep. 
Family History: No H/O BP/ HTN / Infertility / PCOS  
Husband: Husband had a private job and had a 
normal Semen Analysis. 
Menstrual History: She attained her menarche at 
the age of 13 Years. Since 2 Years she had a 
menstrual cycle of 3-5 days duration, with an interval 
of 45-90 days. Moderate bleeding (2-3 fully soaked 
Pads/Day) was observed with mild pain in abdomen 
which was relieved by rest during first 2 days of 
cycle. 
Obstetric History: She had a history of spontaneous 
abortion occurred at 2nd month of pregnancy before 2 
Years. Her obstetric history was Gravida1, Abortion1 
(G 1A1). 
Clinical findings: On examination she was an obese 
woman with android body habits (Apple shaped 
Obesity) with a height of 156cm and weight 73kg 
having BMI 30.41Kg/m2. Her BP was 130/86mmHg 
and a pulse of 78/mt. She was a mild hirsute with 
moderate grade acne over face (cheeks and forehead) 
and neck, acanthosis nigricans over nape of neck 
extending to lateral margins of neck. She is of 
Pittakapha Prakruti with madhyama satva and 
madhyama koshta. 
Gynaecological examination: On examination an 
anteverted normal uterus was found with no other 
abnormalities.  
Investigations: Ultrasonography of Pelvis was done 
to diagnose polycystic ovaries and ovulation study 
was done to rule out anovulation (Table 1). USG-
Pelvis done on 21/4/2017 revealed a normal 
anteverted uterus and bulky ovaries with bright 
stroma and multiple small follicles. Ovulation study 
was done on 14th-23rd day of cycle before and after 
treatment revealed anovulation. The patient was 
advised to do S.TSH before treatment to rule out 
hypothyroidism. Detailed history of investigations BT 
and AT was given in table form (Table 2).  
Diagnosis: Based on Rotterdam Criteria for 
diagnosis of PCOS, after the analysis of signs and 
symptoms like Oligomenorrhoea/ Anovulation, 
androgenic features like hirsutism, android obesity 
etc. along with the help of sonography, Polycystic 
Ovarian Syndrome (PCOS) was confirmed. As per 
Ayurveda the condition is taken as Granthibhuta 
Artavadushti and treatment was planned accordingly. 
Treatment: The therapeutic plan was Sodhana 
chikitsa (purification therapy) followed by Samana 
chikitsa(oral medication). Yogabasti (medicated 
enema) was planned for Sodhana, before Basti, Agni 
was corrected by Deepana and Pachana with 
Amapachana vati[13] for 3 days followed by a Koshta 
Sodhana (emptying bowel) with Erandabhrishta 
Haritaki.[14] Palasadi basti[15] was selected as 
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Niruhabasti and Tilataila was used for 
Anuvasanabasti and Pathadi choorna[16] was given as 
internal medicine for 3 months. Yogabasti was 
repeated in next cycle also. Detailed treatment plan is 
depicted in Table 3. A healthy diet plan and lifestyle 
modification was advised to the patient since PCOS is 
considered as a lifestyle disease. 
Follow up and Outcomes: The assessment was done 
during each menstrual cycle and ovulation study was 
carried out before and after 3 months of treatment. 
The weight of the patient is reduced by 4 kg after two 
cycles of basti and oral medication. The weight is 
maintained at 70 kg during the follow-up period also. 
The cycles remained at an interval of 45 to 60 days 
and ovulation study was also negative during the 
treatment. After 3 months of treatment one cycle 
occurred at an interval of 35 days and then the 
patient again came with the complaint of delayed 
menses since 15 days on 30/8/17. The patient was 
advised to do Urine pregnancy test and found as 
positive. The pregnancy was confirmed by 
ultrasonography. The patient was advised to take 
proper rest and avoid coitus during the first 3 
months of pregnancy to prevent abortion. Ayurvedic 
antenatal care was given to the patient throughout 
pregnancy with regular antenatal check up at our 
Hospital. The BP and blood sugar were normal during 
antenatal period and no other complications were 
found during that period. The patient delivered a 
female baby with a birth weight of 2.75 kg vaginally 
at 39th week of pregnancy. The delivery period also 
was uneventful.  
Table 1: USG Report of Patient 
Date Rt Ovary Lt Ovary Endometrial 
Thickness 
Remarks 
21/4/2017(4th day of LMP) BT 25.3 cc vol 24cc vol  4mm PCOD++ 
14/8/17(5th day of LMP)AT 23cc 19cc  4.6mm PCOD+ 
Table 2: Main Investigations 
 Haematology B.T A.T Differential WBC Count (%) B.T A.T 
Total WBC(/Cu.mm) 5400 4800 Neutrophils 54 64 
Hb (gm%) 13.4 13.1 Lymphocytes 40 30 
E.S.R (mm/1st hr/ Westergren.) 46 46 Eosinophils 03 03 
Total.R.B.C Count (mil/cumm) 4.30 4.04 Monocytes 03 03 
Platelet Count (103/ul) 412 334 Basophils 00 00 
Biochemistry B.T A.T Biochemistry B.T A.T 
FBS (mg/dl) 85 95 S.G.P.T. (IU/L) 29 19 
S.Cholesterol (mg/dl) 159 161 S.G.O.T. (IU/L) 25 17 
S.Triglyceride (mg/dl) 90 73 T.Protein (gm/dl) 7.1 7.6 
HDL Cholesterol (mg/dl) 33 39 Alkaline Phosphatase (IU/L) 51 56 
LDL Cholesterol (mg/dl) 108 107 Uric acid (mg/dl) 3.6 4.6 
Blood Urea (mg/dl) 12 13 S.Testosterone (ng/dl) 35.8  
S.Creatinine (mg/dl) 0.8 1 S.TSH (μIU/ml) 1.414  
Table 3: Treatment Protocol 
Treatment Procedure Method of Administration Treatment duration 
Dipana, Pachana with 
Amapachana vati 
2 bd with warm water orally before 
food 
3 days 
Koshta sodhana with 
Erandabhrishta hareetaki 
15 gm given with warm water at night 1 day 
Palasadi Yogabasti Niroohabasti with 750ml (approx.) 
Palasabasti and Anuvasana basti with 
80ml of Tilataila (Per Rectal) 
8 days (after 
menstruation for 2 
cycles) 
Samana with Pathadi 
choorna 
6gm bd with hot water orally after 
food 
3 months 
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Table 4: Ingredients of Amapachana Vati Ref. Chikitsa Pradip 
S.No. Drug Botanical/Latin name Parts used Quantity 
1 Haritaki Terminalia chebula Retz. Dried fruit 1 part 
2 Sunthi Zingiber officinale Roscoe Rhizome 1 part 
3 Marica Piper nigrum Linn. Fruit 1 part 
4 Pippali Piper longum Linn. Fruit 1 part 
5 Suddha Karaskara Strychnos nuxvomica Linn. Seed 1 part 
6 Hingu Ferula foetida Linn. Exudate 1 part 
7 Goghrta Cow’s ghee   
8 Saindhava Rock salt Mineral 1 part 
9 Kumari  Swarasa Aloe barbedensis Mill Leaf Q.S 
Table 5: Ingredients of Erandabhrishta Hareethaki (Ref. Nighantu. Ratnakar, Shlipada Rogadhikar) 
S.No. Drug Botanical/Latin name Parts used Quantity 
1 Erandtaila Ricinus communis Linn. Oil from the seeds Q.S 
2 Haritaki Terminalia chebula Retz. Dried fruit 1 part 
Table 6: Ingredients of Pathadi Choorna (Ref.Susrutha Samhita Sa.2/14) 
S.No Drugs Botanical Name Parts used Quantity 
1 Patha Cissampelos pareira.Linn.  Dried Root 1 part 
2 Pippali Piper longum Linn.  Dry Fruit 1part 
3 Sunthi Zingiber officinale Roxb.  Dry Rhizome 1 part 
4 Marica Piper nigrum Linn.  Dry Fruit 1 part 
5 Vrikshaka Holarrhena antidysentrica Linn.  Dried Seed 1 part 
Table 7: Ingredients of Palasa Nirooha Basti* (Ref. Charaka Samhita Si.3/44-45) 
 
S.No 
Drug Name Mode of  
Administration 
Botanical Name  Part Used Quantity 
1 Palasa Kwatha Butea Monosperma (Lam.) 
kuntze  
Dried Stem 
Bark 
500 ml (from 
125gm coarse 
powder) 
2 Satahva Kalka Anethum sowa Kurz.  Dried Seeds 30 gm 
3 Vacha Kalka Acorus calamus Linn.  Rhyzome 15 gm 
4 Magadhika Kalka Piper longum Linn.  Dry Fruit 15 gm 
5 Madhu  - Apis cerana Fabr.   - 75 gm 
6 Saindhava  - Soddi Chlorodum.  - 6 gm 
7 Tila taila Taila Sesamum indicum Linn.  Seed oil 150 ml 
Preparation of Basti dravya for Nirooha: Basti 
dravya was prepared by mixing in the order of 
Saindhava, Madhu, Taila, Kalka, Kashaya and finally a 
homogenous mixture was formed. This mixture was 
filtered and used for Nirooha Basti.  
Yoga basti Procedure 
 Palasa basti was used as Nirooha basti and 
Tilataila for Sneha basti. 1st 2 days Sneha basti was 
done, then alternate 3 Nirooha and 2 Sneha basti and 
ends with one Sneha basti. Nirooha basti was 
administered in empty stomach and Sneha basti after 
the intake of food. 
Poorva Karma: Sthanika Abhyanga (Local massage 
of abdomen and low back) with Bala Taila for 15-20 
min and after that local Swedana was done for 15-20 
min. 
Pradhana Karma: Enema can was filled with the 
lukewarm Basti dravya and Nirooha basti dravya was 
administered per rectally to the patient in left lateral 
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position with enema nozzle which is connected to an 
enema can. 
Pashcat Karma: After return of Basti dravya and 
evacuation of bowel, patient was advised hot water 
bath and intake of food. Proper rest was advised after 
Nirooha Basti. 
Sneha Basti: Bed rest for at least 1 hour and hot 
water bag Swedana for abdomen. 
DISCUSSION 
The incidence of Polycystic Ovarian 
Syndrome in India is increasing due to improper 
dietary habits and sedentary lifestyle. Even though 
PCOS can be considered as Vatakapha predominant 
Tridoshaja vyadhi at final stage, Kapha is the 
predominant Dosha involved in the initial Samprapti 
of this disease. Due to the sedentary lifestyle and 
increased intake of fast foods irrespective of appetite 
lead to Jatharagnidushti (impairment of metabolism) 
and Ama formation (metabolic waste products 
accumulation). The patient is continuing the 
improper Ahara and Vihara without much physical 
activity lead to formation of Vikrutadoshas especially 
Malaroopa kapha and further progress to the level of 
Dhatvagnimandya. The similarity in Kapha and 
Rasadhatu causes Rasadhatudushti at the initial level; 
hence formation of Artava is affected and manifested 
as Oligomenorrhoea. The increased Kapha along with 
Ama which prevents normal functioning of Vata, 
which results in impaired hpo axis (Prana), improper 
nourishment of Dhatus by Vyana (increased Medo 
dhatu in obese patients and decreased Dhatus in lean 
PCOS), vitiated Apana affects the Artava nishkramana 
function leads to amenorrhoea/Oligomenorrhoea. 
The normal Doshas plays a significant role in the 
ovulatory cycle also. For the proper maturation and 
rupture of follicle in the ovary Vata and Pitta plays an 
important role along with Agni. Due to vitiated Vata 
and Kapha which blocks the function of Pitta leads to 
improper maturation of follicles and forms small 
cysts. The increased number of cysts in ovary 
produces a Sophavastha in the ovary (bulky ovaries). 
Evidences also suggest that a low grade chronic 
inflammation is present in ovary of PCOS patients. In 
this case the patient was obese with Pittakapha 
prakruti and with Vatakaphadushti along with Rakta 
exhibited as moderate grade acne in face and neck 
with few pustules. The vitiated Kapha along with Ama 
causes vitiation of Rasavaha, Raktavaha, Mamsavaha, 
Medovaha and Artavavaha srotases and produces 
symptoms like heaviness of body, laziness, excess 
sleepiness, abdominal obesity, hirsutism, weakness 
of body, Oligomenorrhoea, infertility etc. The 
treatment procedure was aimed to remove the 
Amavastha prevailed in the disease by proper Dipana 
and Pachana and Sodhana, thus improving the Agni 
and to stabilize the Doshas in the normal state. Basti 
is mainly indicated in Vatika disorders Even though 
Basti is mentioned in vitiation of all the Vata, Pitta, 
Kapha and Raktadosha disorders. Hence Bastikarma 
was administered after Mrudu sodhana. The most of 
drugs in Palasabasti are Katuthikta rasa, Ushna virya, 
Katu vipaka, Lekhana and Vatakaphahara in action. 
Overall Palasabasti helps in Srotosodhana by 
removing vitiated Doshas especially Vatakapha and 
also having specific action in gynaecological 
disorders as it is indicated in Yonidoshas. Tilataila 
was selected for Anuvasanabasti due to the 
properties of Vatakaphahara, Lekhana, Vyavayi, 
Vikasi, Garbhasaya sodhana, vrishya and specially 
Brimhana for Krisa and Lekhana for Sthoola. Pathadi 
choorna mentioned in Granthibhoota artavadushti 
helps to maintain the Agni by its Dipana, Pachana and 
Vatakaphahara by Katu rasa and Ushna virya and 
Pittaprakopa was not occurred due to its 
Madhuravipaka. Pathadi choorna also helped to 
maintain the proper metabolism in PCOS patients 
and thereby maintaining the weight. The Vrishya 
action of Palasabasti and Tilataila also helped the 
patient to conceive during the follow-up period. 
CONCLUSION 
The Ayurvedic treatment protocol including 
Sodhana and Samana helped in improving the 
ovulation, oocyte quality, and endometrial receptivity 
and finally resulted in a live birth with no further 
complications during the antenatal period in an 
infertility patient with previous history of abortion. 
As 5-10% weight reduction is the first line 
management of PCOS, it can be achieved and 
regulated by Ayurvedic medicines especially Pathadi 
Choorna which can be easily made available as it 
contains only 5 drugs. Ovulation can be restored with 
medicine but decreased cumulative pregnancy rate 
was a problem for conception in PCOS patients. The 
conception rate can be increased by proper 
Ayurvedic treatment protocol. This case study helps 
to plan a treatment protocol in PCOS patients having 
infertility.  
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